BAL
Click for more information
0.00% $13.23 bellamy's australia limited

CFDA Approval critical

  1. PatienceToWin
    12,909 Posts.
    lightbulb Created with Sketch. 1006
    clock Created with Sketch.
    15/10/17
    07:23
    Post #: 27911484
    http://www.caixinglobal.com/2017-10-13/101156054.html If BAL can obtain CFDA approval next year we will see a big re-rating and the SP will move quickly above $20
    BAL Price at posting: $10.51 Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 5  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply
 

Featured News

M2R Miramar upgrades target within WA's Gidji, suggests extension to Northern Star's 8 Mile Dam
right-arrow Created with Sketch.
AT1 This stock provides Oz's only HIV self-test kit – and it's bullish on the budget
right-arrow Created with Sketch.
SBW The home PC changed retail stores forever. Shekel Brainweigh can do it again
right-arrow Created with Sketch.
BRX Sampling in Argentina points the way to a base metals porphyry for Belararox
right-arrow Created with Sketch.
RCE Recce Pharma heading closer to full efficacy data for flagship R327
right-arrow Created with Sketch.
BPH BPH Energy reveals high-profile firms included in latest $1M placement
right-arrow Created with Sketch.

Top Stories

watchlist Created with Sketch. Add BAL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.